Use of Steroids in COVID-19 Patients
Use of Steroids in COVID-19 Patients
steroids are useful in reduction of mortality of COVID-19 patients till further evidence. However, steroids should be used in supervision of physician only as unnecessary and overuse of steroids could results in various adverse drug reactions.

Use of Steroids in COVID-19 Patients

The COVID-19 infection has been affecting every one of us for the last year and continues to affect us so far through various new strains. Recently, a new variant, i.e., the Omicron of COVID-19, emerged and started spreading across the globe.The major objective today is to save as many patients as we can from the lethal effects of this virus. Reports have shown the massive increase in various inflammatory mediators in COVID-19 patients, resulting in cytokine storms and death. Steroids are well-known powerful anti-inflammatory agents available on the market for the management of various diseases. Thus, use of steroids in COVID-19 patients could have the potential to reduce mortality. However, there is a lot of confusion regarding the use of steroids in COVID-19 patients, as unnecessary use of these agents could result in various adverse drug reactions (ADRs). This article briefly presents the role of the immune system and the importance of steroids in COVID-19 patients. Further, the main findings of the recent meta-analysis done by our team are also summarized.

COVID-19  is already declared a pandemic by the World Health Organization and various new strains are also emerging across the globe and creating havoc. Vaccines are developed and showing promising results in the prevention of this infection. The role of vaccines against new strains is completely unclear so far. Further, till now, no specific drug is available for its treatment. Various classes of drugs such as specific antibiotics like doxycycline, azithromycin, etc., anthelmintics like ivermectin, anti-gout agents like cholchicine, anti-viral agents like remedesivir, favipiravir, etc., monoclonal antibodies like trastuzumab, antimalarirals like hydroxychoroquinin, anti-inflammatory agents like indomethacin, and analgesics and antipyretics like paracetamolare are being used in the management of COVID-19 patients depending upon the condition of the individual. Researchers across the globe are working hard to come up with a specific molecule against this infection.

The SARS-CoV-2 enters the body and spikes a protein specifically attached to the angiotensin-converting enzyme (ACE-2) of the host, followed by entry of the virus inside the cell. The SARS-Cov-2 is a single-stranded RNA virus that uses the machinery of the host cell to make millions of copies. As we know, that immune system  play a significant role in protection of body against exogenous agents. Immune system is broadly divided into two parts i.e. innate immune system and adaptive immune system. The skin, mucous membranes, white blood cells (WBCs) are part of innate immune system whereas T and B cells are parts of the adaptive immune system. Normally, skin protects us against harmful agents through keratin protein but if exogenous agents enter through mouth, nose etc, the mucous membrane contains specific enzymes which do degradation of these agents. Further, if exogenous agents entersinto blood circulation, WBCs will do the degradation and removal through the process of phagocytosis. The most important feature of immune system is to distinguish between self and non-self. The specific type of receptors called pattern recognition receptors (PRRs) act as a sensor for pathogen associated molecular pattern (PAMPs) of exogenous agents. The Toll like receptors (TLRs) is well known example of PRRs. If innate immune system is unable to handle as in case of SARS-Cov-2 infection, adapative immune system is activated. The activation of adaptive immune system usually take 5-7 days for activation and is activated through innate immune system. The antigen presenting cells (APCs) like dendritic cells, WBCs etc present the processed viral protein to T cell (adaptive immune system).  The presenation of antigen is done through specific protein i.e. major histocompatibility complex (MHCs) and co-stimulatory signals. The activation of T cells release various cytokines which result in the clonal expansion. The released cytokines kill the antigen as well as activate cytotoxic T cells. The released cytokines also activates the B cells to produce antibodies. Unfortunatley, in case of SARS-Cov-2 infection, in some of cases, the immune system is unable to handle and result in overactivation which result in release of excessive cytokines. The excess release of cytokines could result in the death of patients also.

Unlock mroe insights: https://www.pharmafocusasia.com/articles/use-of-steroids-in-covid-19-patients

 

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations